Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1996 Sep;33(9):731–736. doi: 10.1136/jmg.33.9.731

Attitudes towards cancer predictive testing and transmission of information to the family.

C Julian-Reynier 1, F Eisinger 1, P Vennin 1, F Chabal 1, Y Aurran 1, C Noguès 1, Y J Bignon 1, M Machelard-Roumagnac 1, C Maugard-Louboutin 1, D Serin 1, B Blanc 1, P Orsoni 1, H Sobol 1
PMCID: PMC1050725  PMID: 8880571

Abstract

Before the organisation of breast cancer predictive testing in France, consultands' attitudes towards this kind of testing and towards passing on information about the family cancer risk to their relatives were investigated. This survey was carried out from January 1994 to January 1995 at six specialised cancer genetic clinics located in different parts of France Female consultands who were first degree relatives of cancer patients and who had at least one case of breast cancer in their family, affecting either themselves or a first degree relative or both, participated in this study. Among the 248 eligible consultands attending the clinics during the study period, 84.3% answered a post-consultation questionnaire. Among the 209 respondents, 40.7% (n = 85) were cancer patients and 59.3% (n = 124) were healthy consultands. A high consensus in favour of genetic testing was noted, since 87.7% of the sample stated that they would ask for breast cancer gene testing if this test became available. The underlying assumption of 96.6% of the women was that their health surveillance would be improved after a positive test. A high awareness of the anxiety that would be generated in a family after a positive result was observed and found to be associated (p < 0.05) with the anxiety and depressive profiles of the patients. Half of the healthy respondents said they would not change their attitude towards screening if the results of predictive testing turned out to be negative. Only 13.7% of the 161 patients who stated that the oncogeneticists asked them to contact their relatives firmly refused to do so, mainly because of difficult family relationships.

Full text

PDF
731

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrieu N., Clavel F., Auquier A., Lê M. G., Gairard B., Piana L., Brémond A., Lansac J., Flamant R., Renaud R. Variations in the risk of breast cancer associated with a family history of breast cancer according to age at onset and reproductive factors. J Clin Epidemiol. 1993 Sep;46(9):973–980. doi: 10.1016/0895-4356(93)90164-v. [DOI] [PubMed] [Google Scholar]
  2. Ayme Ségolène, Macquart-Moulin Geneviève, Julian-Reynier Claire, Chabal Françoise, Giraud Francis. Diffusion of information about genetic risk within families. Neuromuscul Disord. 1993 Sep-Nov;3(5-6):571–574. doi: 10.1016/0960-8966(93)90118-4. [DOI] [PubMed] [Google Scholar]
  3. Babul R., Adam S., Kremer B., Dufrasne S., Wiggins S., Huggins M., Theilmann J., Bloch M., Hayden M. R. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease. JAMA. 1993 Nov 17;270(19):2321–2325. [PubMed] [Google Scholar]
  4. Bilimoria M. M., Morrow M. The woman at increased risk for breast cancer: evaluation and management strategies. CA Cancer J Clin. 1995 Sep-Oct;45(5):263–278. doi: 10.3322/canjclin.45.5.263. [DOI] [PubMed] [Google Scholar]
  5. Chaliki H., Loader S., Levenkron J. C., Logan-Young W., Hall W. J., Rowley P. T. Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health. 1995 Aug;85(8 Pt 1):1133–1135. doi: 10.2105/ajph.85.8_pt_1.1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Craufurd D., Dodge A., Kerzin-Storrar L., Harris R. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet. 1989 Sep 9;2(8663):603–605. doi: 10.1016/s0140-6736(89)90722-8. [DOI] [PubMed] [Google Scholar]
  7. Croyle R. T., Lerman C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev Med. 1993 Mar;22(2):284–292. doi: 10.1006/pmed.1993.1023. [DOI] [PubMed] [Google Scholar]
  8. Easton D. F., Ford D., Bishop D. T. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995 Jan;56(1):265–271. [PMC free article] [PubMed] [Google Scholar]
  9. Evans D. G. Genetic testing for cancer predisposition: need and demand. J Med Genet. 1995 Mar;32(3):161–161. doi: 10.1136/jmg.32.3.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Evers-Kiebooms G., Cassiman J. J., van den Berghe H. Attitudes towards predictive testing in Huntington's disease: a recent survey in Belgium. J Med Genet. 1987 May;24(5):275–279. doi: 10.1136/jmg.24.5.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Futreal P. A., Liu Q., Shattuck-Eidens D., Cochran C., Harshman K., Tavtigian S., Bennett L. M., Haugen-Strano A., Swensen J., Miki Y. BRCA1 mutations in primary breast and ovarian carcinomas. Science. 1994 Oct 7;266(5182):120–122. doi: 10.1126/science.7939630. [DOI] [PubMed] [Google Scholar]
  12. Grody W. W. The coming era of cancer genetic screening. Diagn Mol Pathol. 1994 Sep;3(3):145–146. doi: 10.1097/00019606-199409000-00001. [DOI] [PubMed] [Google Scholar]
  13. Hietala M., Hakonen A., Aro A. R., Niemelä P., Peltonen L., Aula P. Attitudes toward genetic testing among the general population and relatives of patients with a severe genetic disease: a survey from Finland. Am J Hum Genet. 1995 Jun;56(6):1493–1500. [PMC free article] [PubMed] [Google Scholar]
  14. Hoskins K. F., Stopfer J. E., Calzone K. A., Merajver S. D., Rebbeck T. R., Garber J. E., Weber B. L. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA. 1995 Feb 15;273(7):577–585. [PubMed] [Google Scholar]
  15. Julian-Reynier C., Eisinger F., Chabal F., Aurran Y., Noguès C., Vennin P., Bignon Y. J., Machelard-Roumagnac M., Maugard-Louboutin C., Serin D. Cancer genetics clinics: target population and consultees' expectations. Eur J Cancer. 1996 Mar;32A(3):398–403. doi: 10.1016/0959-8049(95)00601-x. [DOI] [PubMed] [Google Scholar]
  16. Kessler S., Field T., Worth L., Mosbarger H. Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet. 1987 Feb;26(2):259–270. doi: 10.1002/ajmg.1320260204. [DOI] [PubMed] [Google Scholar]
  17. Lerman C., Daly M., Masny A., Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994 Apr;12(4):843–850. doi: 10.1200/JCO.1994.12.4.843. [DOI] [PubMed] [Google Scholar]
  18. Lerman C., Seay J., Balshem A., Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet. 1995 Jul 3;57(3):385–392. doi: 10.1002/ajmg.1320570304. [DOI] [PubMed] [Google Scholar]
  19. McPherson K., Steel C. M., Dixon J. M. ABC of breast diseases. Breast cancer--epidemiology, risk factors and genetics. BMJ. 1994 Oct 15;309(6960):1003–1006. doi: 10.1136/bmj.309.6960.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Meissen G. J., Berchek R. L. Intended use of predictive testing by those at risk for Huntington disease. Am J Med Genet. 1987 Feb;26(2):283–293. doi: 10.1002/ajmg.1320260206. [DOI] [PubMed] [Google Scholar]
  21. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. doi: 10.1126/science.7545954. [DOI] [PubMed] [Google Scholar]
  22. Moatti J. P., Le Gales C., Julian C., Durbec J. P., Mattei J. F., Ayme S. Socio-cultural inequities in access to prenatal diagnosis: the role of insurance coverage and regulatory policies. Prenat Diagn. 1990 May;10(5):313–325. doi: 10.1002/pd.1970100507. [DOI] [PubMed] [Google Scholar]
  23. Motulsky A. G. Predictive genetic diagnosis. Am J Hum Genet. 1994 Oct;55(4):603–605. [PMC free article] [PubMed] [Google Scholar]
  24. Narod S. A., Ford D., Devilee P., Barkardottir R. B., Lynch H. T., Smith S. A., Ponder B. A., Weber B. L., Garber J. E., Birch J. M. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995 Jan;56(1):254–264. [PMC free article] [PubMed] [Google Scholar]
  25. Skolnick M. H., Cannon-Albright L. A. Genetic predisposition to breast cancer. Cancer. 1992 Sep 15;70(6 Suppl):1747–1754. doi: 10.1002/1097-0142(19920915)70:4+<1747::aid-cncr2820701616>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  26. Sobol H., Birnbaum D., Eisinger F. Evidence for a third breast-cancer susceptibility gene. Lancet. 1994 Oct 22;344(8930):1151–1152. doi: 10.1016/s0140-6736(94)90655-6. [DOI] [PubMed] [Google Scholar]
  27. Struewing J. P., Lerman C., Kase R. G., Giambarresi T. R., Tucker M. A. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):169–173. [PubMed] [Google Scholar]
  28. Thompson W. D. Genetic epidemiology of breast cancer. Cancer. 1994 Jul 1;74(1 Suppl):279–287. doi: 10.1002/cncr.2820741312. [DOI] [PubMed] [Google Scholar]
  29. Vasen H. F. Screening in breast cancer families: is it useful? Ann Med. 1994 Jun;26(3):185–190. doi: 10.3109/07853899409147888. [DOI] [PubMed] [Google Scholar]
  30. Watson M., Murday V., Lloyd S., Ponder B., Averill D., Eeles R. Genetic testing in breast/ovarian cancer (BRCA1) families. Lancet. 1995 Aug 26;346(8974):583–583. doi: 10.1016/s0140-6736(95)91424-2. [DOI] [PubMed] [Google Scholar]
  31. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995 Dec 21;378(6559):789–792. doi: 10.1038/378789a0. [DOI] [PubMed] [Google Scholar]
  32. van der Steenstraten I. M., Tibben A., Roos R. A., van de Kamp J. J., Niermeijer M. F. Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. Am J Hum Genet. 1994 Oct;55(4):618–625. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES